Comparative effectiveness of newer oral diabetes medications in preventing advanced diabetic retinopathy
Comparative effectiveness of newer oral diabetes medications in preventing advanced diabetic retinopathy
新型口服糖尿病药物预防晚期糖尿病视网膜病变的效果比较
批准号：
408587
负责人：
Campbell Robert J
金额：
$9.47万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-09-01 至 2022-09-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Diabetic retinopathy (DR) is the most common complication of diabetes and is the leading cause of blindness and vision impairment in working-age adults. Pivotal studies have established that tight control of blood glucose levels decreases the risk of deve
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comparative safety of aflibercept and ranibizumab in the treatment of retinal diseases
-
批准号：345673
-
项目类别：Operating Grants
-
资助金额：$8.01万
-
财政年份：2016
-
负责人：Campbell Robert J
-
依托单位：
Cardiovascular and Ocular Adverse Events Associated with New Treatments for Age-Related Macular Degeneration
-
批准号：202140
-
项目类别：Operating Grants
-
资助金额：$12.89万
-
财政年份：2010
-
负责人：Campbell Robert J
-
依托单位：
海外基金
